What to Expect: Clinical Trials For Atrial Fibrillation
Participant safety is our top priority, and all volunteers complete a comprehensive screening process to determine eligibility. This screening process includes:
Atrial fibrillation (AFib) is a heart condition characterized by an irregular and often rapid heartbeat that can affect how efficiently the heart pumps blood. It may cause symptoms such as heart palpitations, fatigue, shortness of breath, and dizziness, although some people experience no symptoms. Treatment options, including lifestyle changes, medications, and procedures, may help manage symptoms, support heart health, improve quality of life, and reduce the risk of complications.


Qualifications For An Atrial Fibrillation Clinical Trial:
As a participant in our clinical trial, certain eligibility criteria must be met. If you qualify, we invite you to consider participating and helping advance the development of potential new treatments.
You may be eligible to participate if you:
– Have a documented diagnosis of Atrial Fibrillation
– Are not on anti-coagulants
– At least 18+
* Other criteria may apply. Click to see if you qualify today!
Reasons to Join A Clinical Trial
In addition to improving your quality of life and supporting the development of new treatments, participating in a clinical trial may offer additional benefits for participants.
Frequently Asked Questions:


Join An Atrial Fibrillation
Clinical Trial Today!
Join our clinical trial and help advance potential new treatment options. Complete the form today to see if you qualify.



